← Back to Search

Behavioral Intervention

Education Program for Breast Cancer

N/A
Waitlist Available
Led By Ann Partridge, MD, MPH
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years of age or older
Biologically female
Must not have
Adults unable to consent
Individuals who are not yet adults (infants, children, teenagers)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 14 weeks
Awards & highlights

Summary

This trial is testing a program called Endocrine Therapy Education Program to see if it can help improve the experiences of people on Endocrine Therapy.

Who is the study for?
This trial is for individuals with breast cancer who are undergoing or about to start endocrine therapy. The study aims to help participants better understand and adhere to their treatment regimen.
What is being tested?
The focus of the trial is on a video-based Endocrine Therapy Education Program designed to enhance patients' understanding of their therapy, potentially improving adherence and overall experience.
What are the potential side effects?
Since this trial involves an educational program rather than a medical treatment, there are no direct side effects associated with it.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
I am biologically female.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to give consent for myself.
Select...
I am under the age of 18.
Select...
My cancer has spread to other parts of my body.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 14 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 14 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Engagement Rate of Intervention
Intervention Satisfaction Questionnaire Mean Score Group A
Intervention Satisfaction Questionnaire Mean Score Group B

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Group A: Endocrine Therapy Education InterventionExperimental Treatment1 Intervention
Participants will complete: Baseline visit. Educational video once a week for 6 weeks. 6-week survey. 3-month survey.
Group II: Group B: Wait-List Control GroupActive Control1 Intervention
Participants will complete: Baseline visit. 6-week survey. 3-month survey. Access to intervention educational videos. 2-week post video survey.

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,085 Previous Clinical Trials
341,704 Total Patients Enrolled
142 Trials studying Breast Cancer
22,616 Patients Enrolled for Breast Cancer
Ann Partridge, MD, MPHPrincipal InvestigatorDana-Farber Cancer Institute
1 Previous Clinical Trials
997 Total Patients Enrolled
~51 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top